Developing in vitro models of human ductal carcinoma in situ from primary tissue explants-Reference-Cited by-同舟云学术

Developing in vitro models of human ductal carcinoma in situ from primary tissue explants

Published:2015-08-18 Issue:2 Volume:153 Page:311-321
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Brown Daniel D.,Dabbs David J.,Lee Adrian V.,McGuire Kandace P.,Ahrendt Gretchen M.,Bhargava Rohit,Davidson Nancy E.,Brufsky Adam M.,Johnson Ronald R.,Oesterreich Steffi,McAuliffe Priscilla F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3551-8.pdf

Reference35 articles.

1. Fonseca R, Hartmann LC, Petersen IA, Donohue JH, Crotty TB, Gisvold JJ (1997) Ductal carcinoma in situ of the breast. Ann Intern Med 127(11):1013–1022

2. Mukhtar RA, Wong JM, Esserman LJ (2015) Preventing Overdiagnosis and overtreatment: just the next step in the evolution of breast cancer care. J Nat Compr Cancer Netw 13(6):737–743

3. Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103(12):2481–2484. doi: 10.1002/cncr.21069

4. Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD (2015) Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol 28(5):662–669. doi: 10.1038/modpathol.2014.141

5. Erbas B, Provenzano E, Armes J, Gertig D (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97(2):135–144. doi: 10.1007/s10549-005-9101-z

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research;Cells;2023-09-30

2. Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation;Cells;2023-06-24

3. Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients;Cancer Research Communications;2022-12-13

4. Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells;Scientific Reports;2022-04-22

5. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review);International Journal of Oncology;2022-03-24